ZA943754B - Process for the sterilization of biological compositions and the product produced thereby - Google Patents

Process for the sterilization of biological compositions and the product produced thereby

Info

Publication number
ZA943754B
ZA943754B ZA943754A ZA943754A ZA943754B ZA 943754 B ZA943754 B ZA 943754B ZA 943754 A ZA943754 A ZA 943754A ZA 943754 A ZA943754 A ZA 943754A ZA 943754 B ZA943754 B ZA 943754B
Authority
ZA
South Africa
Prior art keywords
composition
type
compound
irradiation
reactions
Prior art date
Application number
ZA943754A
Other languages
English (en)
Inventor
Bernard Horowitz
Bolanie Williams
Henrietta Margolis-Nunno
Sing N Chin
Original Assignee
New York Blood Center Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New York Blood Center Inc filed Critical New York Blood Center Inc
Publication of ZA943754B publication Critical patent/ZA943754B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0023—Agression treatment or altering
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0066—Psoralene-activated UV-A photochemotherapy (PUVA-therapy), e.g. for treatment of psoriasis or eczema, extracorporeal photopheresis with psoralens or fucocoumarins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20211—Vesiculovirus, e.g. vesicular stomatitis Indiana virus
    • C12N2760/20261—Methods of inactivation or attenuation
    • C12N2760/20263—Methods of inactivation or attenuation by chemical treatment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32661—Methods of inactivation or attenuation
    • C12N2770/32663—Methods of inactivation or attenuation by chemical treatment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10111—Myoviridae
    • C12N2795/10161—Methods of inactivation or attenuation
    • C12N2795/10163—Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
ZA943754A 1993-05-28 1994-05-27 Process for the sterilization of biological compositions and the product produced thereby ZA943754B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6923593A 1993-05-28 1993-05-28

Publications (1)

Publication Number Publication Date
ZA943754B true ZA943754B (en) 1995-02-09

Family

ID=22087612

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA943754A ZA943754B (en) 1993-05-28 1994-05-27 Process for the sterilization of biological compositions and the product produced thereby

Country Status (12)

Country Link
EP (1) EP0702719B1 (fr)
JP (1) JP3426237B2 (fr)
KR (1) KR100258377B1 (fr)
AT (1) ATE301186T1 (fr)
AU (1) AU696246B2 (fr)
CA (1) CA2163636C (fr)
DE (1) DE69434445T2 (fr)
ES (1) ES2247587T3 (fr)
FI (1) FI117288B (fr)
NO (1) NO954815L (fr)
WO (1) WO1994028120A1 (fr)
ZA (1) ZA943754B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6077659A (en) * 1990-05-15 2000-06-20 New York Blood Center, Inc. Vitamin E and derivatives thereof prevent potassium ion leakage and other types of damage in red cells that are virus sterilized by phthalocyanines and light
EP0840624B1 (fr) * 1995-07-14 2007-07-25 CAF - DCF cvba - scrl Installation d'inactivation de contaminants viraux presents dans des produits sanguins
US6329136B1 (en) 1998-10-30 2001-12-11 The Regents Of The University Of California Method for laser inactivation of infectious agents
US6635676B2 (en) * 1999-04-28 2003-10-21 Regents Of The University Of Michigan Non-toxic antimicrobial compositions and methods of use
US7655252B2 (en) 1999-04-28 2010-02-02 The Regents Of The University Of Michigan Antimicrobial nanoemulsion compositions and methods
AU2001263200A1 (en) * 2000-05-17 2001-11-26 The American National Red Cross Gamma irradiation of protein-based pharmaceutical products
JP2010209109A (ja) * 2001-06-25 2010-09-24 Regents Of The Univ Of Michigan 抗微生物ナノエマルジョンの組成物および方法
CA2474448C (fr) * 2002-02-01 2010-09-07 Gambro, Inc. Inactivation du virus west nile et de l'agent pathogene de la malaria au moyen de photosensibilisants
AU2004216476B2 (en) 2003-02-27 2009-01-08 Takeda Pharmaceutical Company Limited Method for the validatable inactivation of pathogens in a biological fluid by irradiation
US8613934B2 (en) 2004-03-22 2013-12-24 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Cellular and viral inactivation
WO2009131606A2 (fr) * 2008-02-01 2009-10-29 Belanger Julie M Inactivation virale employant des agents réticulants et des détergents
SI1737492T1 (sl) 2004-04-16 2013-04-30 Bredent Medical Gmbh & Co. Kg Pripravek za fotodinamično zatiranje mikroorganizmov in uporaba pripravka
US20070254349A1 (en) 2004-04-16 2007-11-01 Helbo Photodynamic Systems Gmbh & Co.Kg Preparation for the Photodynamic Control of Micro-Organisms and Use Thereof
DE102006008613A1 (de) 2006-02-24 2007-08-30 Dade Behring Marburg Gmbh Stabilisierte Zubereitungen von Serin-Endopeptidasen, deren Herstellung und Verwendung
US8580192B2 (en) 2006-10-31 2013-11-12 Ethicon, Inc. Sterilization of polymeric materials
WO2008137747A1 (fr) 2007-05-02 2008-11-13 The Regents Of The University Of Michigan Compositions thérapeutiques à base de nanoémulsion et leurs procédés d'utilisation
EP2008669A1 (fr) * 2007-06-22 2008-12-31 Maco Pharma S.A. Appareil d'irradiation pour rendre inactif les pathogènes et/ou leucocytes dans un liquide biologique et processus correspondant
EP2376089B1 (fr) 2008-11-17 2018-03-14 The Regents of the University of Michigan Compositions de vaccins contre le cancer et leurs méthodes d' utilisation
EP2566958B1 (fr) * 2010-05-03 2015-12-30 GlaxoSmithKline Biologicals S.A. Procédé pour l'inactivation du virus de la grippe
EP2771038B1 (fr) * 2011-10-26 2018-10-10 Amgen Inc. Procédés de réduction ou d'élimination de la modification protéique et de la dégradation protéique générées à partir de l'exposition à la lumière uv
KR101936559B1 (ko) * 2016-07-13 2019-01-09 국립암센터 분해가능 연결자를 포함하는 광증감제-펩타이드 결합체 및 그를 포함하는 광역학 진단 또는 치료용 조성물
MX2021015653A (es) 2019-06-22 2022-04-11 Cerus Corp Sistemas de tratamiento de fluidos biologicos.
EP3991179A1 (fr) 2019-06-28 2022-05-04 Cerus Corporation Système et procédés permettant de mettre en oeuvre un dispositif de traitement de fluide biologique
EP4268849A1 (fr) 2020-12-24 2023-11-01 National University Corporation Kobe University Procédé d'inactivation de virus utilisant une exposition ultraviolette

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4049798A (en) * 1974-12-11 1977-09-20 William K. Bottomley Method for the treatment of Herpes Simplex
US4693981A (en) * 1983-12-20 1987-09-15 Advanced Genetics Research Institute Preparation of inactivated viral vaccines
JPS61275228A (ja) * 1985-03-14 1986-12-05 バクスタ−、トラベノ−ル、ラボラトリ−ズ、インコ−ポレイテツド 治療用タンパク組成物中のビ−ルスの光動的不活性化
JPH01175942A (ja) * 1987-12-28 1989-07-12 Sanyo Kokusaku Pulp Co Ltd 抗ウイルス性医薬用組成物
GB8817240D0 (en) * 1988-07-20 1988-08-24 Univ Salford Business Services Sterilising methods
US5120649A (en) * 1990-05-15 1992-06-09 New York Blood Center, Inc. Photodynamic inactivation of viruses in blood cell-containing compositions
US5232844A (en) * 1990-05-15 1993-08-03 New York Blood Center Photodynamic inactivation of viruses in cell-containing compositions
US5211944A (en) * 1990-10-12 1993-05-18 Shaman Pharmaceuticals, Inc. Proanthocyanidin polymers having antiviral activity and methods of obtaining same

Also Published As

Publication number Publication date
EP0702719A1 (fr) 1996-03-27
JP3426237B2 (ja) 2003-07-14
DE69434445D1 (de) 2005-09-08
KR960702864A (ko) 1996-05-23
EP0702719A4 (fr) 1996-08-14
CA2163636A1 (fr) 1994-12-08
DE69434445T2 (de) 2006-05-18
EP0702719B1 (fr) 2005-08-03
KR100258377B1 (ko) 2000-06-01
FI955690A0 (fi) 1995-11-24
AU696246B2 (en) 1998-09-03
ATE301186T1 (de) 2005-08-15
AU7048594A (en) 1994-12-20
NO954815D0 (no) 1995-11-27
ES2247587T3 (es) 2006-03-01
FI955690A (fi) 1996-01-22
CA2163636C (fr) 2002-01-08
WO1994028120A1 (fr) 1994-12-08
FI117288B (fi) 2006-08-31
JPH11503601A (ja) 1999-03-30
NO954815L (no) 1996-01-26

Similar Documents

Publication Publication Date Title
ZA943754B (en) Process for the sterilization of biological compositions and the product produced thereby
CA2042494A1 (fr) Inactivation photodynamique de virus en compositions cellulaires
KR960703625A (ko) 제품의 살균방법(method for sterilizing products)
BR8900229A (pt) Uma composicao sinergistica biocida,uma composicao para higiene pessoal,uma composicao de produto para limpeza domestica e um processo para inibir o crescimento de microorganismos
AU2118488A (en) Improvements in or relating to methods of treating damaged skin
RU94029662A (ru) Фосфонооксиметиловые эфиры производных таксана, фармацевтическая композиция, способы лечения
ES8303087A1 (es) Procedimiento de estabilizar, en medio acuoso, un peroxido de un acido organico y un compuesto eritromicinico.
IL118258A (en) Method of treating extracoporeal blood or blood product to inactivate protozoa parasite by use of phthalocyanines
NO173424C (no) Fremgangsmaate for behandling av nykuttede plantedeler for aa forlenge lagringstiden av disse, og blanding for anvendelse derved
ES2026314A6 (es) Procedimiento para obtener una composicion profilactica antimicrobiana oftalmica neonatal.
IL88971A (en) Disubstituted pyridines, process and intermediates, their preparation and pharmaceutical compositions containing them
MX9301757A (es) Una nueva materia de composicion y metodos para usarla como bioreguladores
Muhn et al. Rapid laser flash photoaffinity labeling of binding sites for a noncompetitive inhibitor of the acetylcholine receptor
Tsukada et al. Bactericidal action of photo-irradiated aqueous extracts from the residue of crushed grapes from winemaking
AU3943397A (en) New antiviral lipopeptides, and a method of inactivating lipid-enveloped viruses using lipopeptides
DK0485486T3 (da) Fremgangsmåde til desinfektion af muskelskeletvæv og således præpareret væv
AU2323788A (en) Treatments to improve the properties of keratinous materials
Hass et al. Human erythrocyte phosphoglycerate mutase: evidence for normal catalysis in the absence of added 2, 3-bisphospho-d-glycerate
DE3485282D1 (de) Zusammensetzung zur behandlung von boesartigen tumoren insbesondere bei tieren.
RU94036666A (ru) Биостимулирующее средство
DE69022027D1 (de) 2-Alkyl-3-benzoylbenzofurane zur Behandlung von Herzarrhythmia.
SU1072420A1 (ru) Бис-[(3,5-ди-трет-бутил-4-оксифенил)-алкил]-сульфиды в качестве термостабилизаторов полиэтилена
GEP19970991B (en) Method for Decay of Tumor Cells with Mammalia and Pharmacentical Composition for this Purpose
SE8202017L (sv) Oral komposition jemte forfarande for dess framstellning
UA8900A1 (uk) Активний наповнювач-пігмент та спосіб його одержання